TP53 and Familial prostate cancer: Moreover, treatment of mutant P53 prostate cancer DU145 cells with Resv induced phosphorylation of the tumor suppressor which restored wild-type P53 DNA binding [61, 62] and P53 acetylation [63], activating proapoptotic events.